November 2021 Issue of The Ophthalmologist

How does long COVID-19 affect the eyes – and can those changes be used for diagnosis?

Just over a year on from the tragedy of the Beirut Port explosion – what eye injuries occurred and how has eyesight changed six months on?

Episode 4: The Olympics of New Tech, in which the IOLs are hoping to win the Crown of Innovation award in the Annual IOL Grand Slam

Can music reduce pain and anxiety in patients while also improving surgical team performance?

Using “CRISPR interference” to combat TGFβ2-induced ocular hypertension

"Leave the quiet ones alone," say the authors of this case study, featuring an intralenticular foreign body

Cannabis use during pregnancy may alter retinal development in offspring, says mouse model study

Serious adverse events occur in all medical specialties – including ophthalmology. Can more be done to prevent them?

From peer review to publication: a guide to the intricacies of publishing in ophthalmology

The introduction of accessible genetic testing for keratoconus helps detect the condition and introduce treatment early

Advanced technologies for intelligent IOL power calculations – even in challenging eyes

These collaborators are looking to ask the right questions through their AMD-specific visual functional assessment

Look before you leap: demystifying post-surgical dry eye disease management

When glaucoma and cataract surgery intersect, it’s important to alter treatment approaches dependent on disease severity

Using protein-based mass spectrometry, researchers have identified a family of proteins responsible for dry AMD pathology that can be therapeutically

A review of gene and genetic therapies for ophthalmic conditions – and what promises they hold

Sitting Down With… Mariya Moosajee, Professor of Molecular Ophthalmology at University College London Institute of Ophthalmology